| This week's sponsor is Premier Research | | | How to Neutralize the Placebo Effect
Placebo response is a natural enemy of any analgesia trial. While it can help, it can also harm. Learn more about this growing phenomenon by catching the start of our 14-part Placebo Problem blogseries. Premier Research. It's what we do. Best. |
Featured Story | | | Wednesday, September 20, 2017 A phase 3 trial of Alnylam’s patisiran has hit all of its primary and secondary endpoints. The clean sweep is a big win for Alnylam and the Sanofi-partnered gene silencing drug, which is now set to be put before regulators around the end of the year. |
|
|
| This week's sponsor is Althea. | | | |
Top Stories Wednesday, September 20, 2017 There’s a lot of money around for young biotechs at the moment. After Flagship said this week it was seeking a $500 million fund, fellow VC Lightstone has $250 million in the bank for life science research. Wednesday, September 20, 2017 Chinese neurological disorders startup XW Laboratories has seen a $17.5 million series B, bumping up its total raise from its first round to $23 million. Monday, September 18, 2017 For pharma and biotech, in which data is the most valuable asset, industry analysts agree that digital transformation presents an opportunity to realize unprecedented productivity gains and competitive advantage. Wednesday, September 20, 2017 Immuno-oncology startup Arcus Bioscience has signed a deal with Japanese drugmaker Taiho that provides a healthy cash injection while keeping rights in the U.S. and other markets in hand. Wednesday, September 20, 2017 Glythera has struck a deal to access a source of antibodies against specified targets. Iontas will use its phage display libraries and other antibody discovery capabilities to provide Glythera with a key component of its planned antibody drug conjugates (ADCs). Wednesday, September 20, 2017 Optinose has filed to raise $100 million in an IPO. The filing comes days after the FDA approved the intranasal delivery specialist’s treatment for nasal polyps, the commercialization of which will be the focus of a post-IPO spending spree. Wednesday, September 20, 2017 Concept Life Sciences has taken two new lab spaces at Alderley Park’s Mereside campus in Cheshire, U.K., increasing its scientific capacity by over 30%, including 55 scientists. The aim is to further drive its growth in discovery and development capabilities. Resources Sponsored by: Ashfield Healthcare Join this webinar to learn how to design, deliver, and measure a successful patient support program. Presented by Nareda Mills, Ashfield's SVP of Patient Services in the US, you’ll discover how to improve adherence and improve patient outcomes using 5 key methods. Presented By: PRA Health Sciences Children participating in pediatric clinical trials are included in the contraceptive requirements applied to women of child-bearing potential, creating significant challenges for sponsors, parents, investigators and study staff. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. 2nd Strategic Partnerships for Drug Repurposing October 26-27, 2017 | Boston, MA Compliance Certificate and Training for Life Sciences Professionals October 9 -12, 2017 | Newark, NJ CBI’s MedComm 2017 Conference October 26-27, 2017 | San Francisco, CA FierceBiotech 2nd Drug Development Forum September 25-27, 2017 | Boston, MA FierceBiotech Executive Summit- London October 2, 2017 | London 11th Digital Pharma East October 3-6, 2017 | Philadelphia, PA Don't Miss This Opportunity | Life Sciences Innovation Awards Application Deadline: Friday, October 20 at midnight EST Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA | 